RxDoctor Payments Data

Emily Schneider-Bruch

Obstetrics & Gynecology · Denver, CONPI 1407098429

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $372 and has fallen 96.0% since, to $15 in 2025.

$1,779in general payments, 2019–2025

Across 96 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$382
  • Bayer$185
  • Astellas Pharma US Inc$169
  • Therapeuticsmd, Inc.$137
  • Mayne Pharma Commercial LLC$118
  • Organon$107
  • plus $680 from 19 others

What the payments were for

  • Food & beverage$1,74998%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,779 in reported general payments places this provider in the 75th percentile of 705 obstetrics & gynecology providers in Colorado.

See all obstetrics & gynecology providers in Colorado →

Other obstetrics & gynecology in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →